The core function of the Screening Group (SCR) at IARC is to provide data on the accuracy, reproducibility, efficacy, benefits, harmful effects, and cost-effectiveness of various early detection interventions for breast, cervical, colorectal, and oral cancers, among others, in reducing deaths and improving patientsí quality of life in various settings. These data can then be used to inform and improve the rational use of health-care resources. The Groupís ultimate objective is to guide the development of public health policies for implementing screening in a variety of health-care settings, in particular in low- and middle-income countries (LMICs).
SCR conducts field studies in LMICs to evaluate various early detection methods for breast, cervical, colorectal, and oral cancer control. These initiatives also address the means by which screening services could be scaled up through local public health services. SCR develops various training resources to catalyse and augment capacity building in close collaboration with national institutions and government health services. Through its research programme, SCR generates scientific evidence to support the development of resource-appropriate early detection policies and health systems for the delivery of effective early services. For example, the Group significantly contributed to the evaluation of the safety and efficacy of less than three doses of the HPV vaccine in protecting against cervical cancer.
Conferences: International Cancer Research and Cancer Control and Japanese Association of Cancer Registries, Tokyo, Japan07/12/2018
Dr Basu presented during the seminar on International Cancer Research and Cancer Control organized by the National Cancer Center (NCC), Japan and gave a lecture at the Japanese Association of Cancer Registries (JACR) Annual Symposium in Tokyo, Japan.
Video IARC in 140 Characters: Dr Ashrafun Nessa - Cervical and Breast Cancer Screening Programme07/12/2018
Professor Ashrafun Nessa, Bangabandhu Sheikh Mujib Medical University Hospital, Bangladesh, explains the challenges of addressing cervical cancer, responsible for one quarter of cancer deaths in Bangladesh, as well as how the government is trying to tackle the disease and how IARC and the Screening Group is helping with the project.
Video IARC in 140 Characters: Dr Anita Gadgil - Breast cancer screening programme in India06/12/2018
Dr Anita Gadgil, Mumbai, India, is involved in a programme in collaboration with the Screening Group to increase breast cancer awareness and deliver breast cancer screening to women in India. She explains how IARC has supported the programme and why this type of intervention is important for low- and middle-income countries.
|Utada M., Chernyavskiy P. Lee W.J., Franceschi S., Sauvaget C., Berrington de Gonzalez A., Withrow D.R. Increasing risk of uterine cervical cancer among young Japanese women: Comparison of incidence trends in Japan, South Korea and Japanese-Americans between 1985 and 2012. Int J Cancer. 2018 Nov 25.|
|Mandal R, Basu P. Cancer screening and early diagnosis in low and middle income countries: Current situation and future perspectives. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Oct 23.|
|Randall T.C., Sauvaget C., Muwonge R., Trimble E.L., Jeronimo J. Worthy of further consideration: An updated meta-analysis to address the feasibility, acceptability, safety and efficacy of thermal ablation in the treatment of cervical cancer precursor lesions. Prev Med. 2018 Oct 17;118:81-91.|